Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
12/2005
12/01/2005WO2005114147A1 Image processor for processing image obtained by imaging colored light-transmitting sample
12/01/2005WO2005114143A1 Non-destructive single seed or several seeds nir analyzer and method
12/01/2005WO2005114142A2 Portable sample analyzer with removable cartridge
12/01/2005WO2005114140A1 A device and method for detecting blood coagulation
12/01/2005WO2005114139A2 Polymer melt and elastomer extension fixture
12/01/2005WO2005114136A1 Oral sensation measuring device for foods
12/01/2005WO2005114107A2 Use of a monoclonal antibody that specifically binds stem cells
12/01/2005WO2005113838A2 Detection of protein translocation by beta-galactosidase reporter fragment complementation
12/01/2005WO2005113835A2 Kits and methods for indentification, assessment, prevention and therapy of breast cancer
12/01/2005WO2005113831A2 Biomarkers for multiple sclerosis and methods of use thereof
12/01/2005WO2005113828A1 Methods of diagnosing and prognosticating solid tumors and melanoma
12/01/2005WO2005113819A2 System and method for smoothing melting curve data
12/01/2005WO2005113817A2 Aptamer-nanoparticle conjugates and method of use for target analyte detection
12/01/2005WO2005113814A2 Biomarkers of chronic pelvic pain syndrome
12/01/2005WO2005113811A2 Combinatorial selection of phosphorothioate aptamers for tgf-beta
12/01/2005WO2005113806A1 Method of diagnosing uveitis
12/01/2005WO2005113805A2 Assays for the identification of modulators of mhc class ii expression
12/01/2005WO2005113800A2 Method and device for monitoring aspirin response
12/01/2005WO2005113799A1 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor kinase 5 (grk5)
12/01/2005WO2005113798A2 Proteolytic markers as diagnostic biomarkers for cancer, organ injury and muscle rehabilitation/exercise overtraining
12/01/2005WO2005113796A1 Biological soil detector and method of using same
12/01/2005WO2005113795A2 Hematology reference control containing an immature granulocyte component
12/01/2005WO2005113794A1 Methods and tools for detecting collagen degradation
12/01/2005WO2005113793A1 Method for introducing protein and/or peptide into cell
12/01/2005WO2005113792A1 Probe for detection/determination of inositol-1,4,5-triphosphoric acid and method of detecting/determining inositol-1,4,5-triphosphoric acid with the same
12/01/2005WO2005113791A2 Methods of identifying modulators of bacterial type iii protein secretion system
12/01/2005WO2005113790A1 Electrochemical assay device and related methods
12/01/2005WO2005113787A2 Diagnostics and therapeutics for diseases associated with g protein-dependent receptor kinase 1 (grk1)
12/01/2005WO2005113786A2 Diagnostics and therapeutics for diseases associated with chymase (cma1)
12/01/2005WO2005113764A2 Modulation of wrn-mediated telomere-initiated cell signaling
12/01/2005WO2005113762A1 CRYSTAL STRUCTURE OF PROTEIN KINASE B-α (AKT-1) AND USES THEREOF
12/01/2005WO2005113740A2 Perfusion system and apparatus for automated multi-channel patch-clamp recordings utilizing inside-out whole-cell configuration
12/01/2005WO2005113739A1 Bio-chemical chip and method of controlling the same
12/01/2005WO2005113720A2 A strategy for designing patient-specific anti-cancer drugs
12/01/2005WO2005113602A1 Coiled-coil microbial antigens
12/01/2005WO2005113588A2 Methods and compositions related to smad anchors for tgfb/bmp receptor activaton
12/01/2005WO2005113587A2 Gene products expressed differentially in tumors and use thereof
12/01/2005WO2005113586A2 Disease-associated proteins
12/01/2005WO2005113524A1 Fluorescent method and compounds to monitor protein-lipid binding
12/01/2005WO2005113468A1 Tracer materials in cementitious compositions and method of identification thereof
12/01/2005WO2005113217A1 Apparatus and process for the formation of a film of fibre
12/01/2005WO2005113129A1 Sol-gel process for the functionalisation of a surface of a solid substrate
12/01/2005WO2005113059A2 Disruption of the processing of the viral capsid-spacer peptide 1 protein
12/01/2005WO2005113036A1 Method and apparatus for glucose control and insulin dosing for diabetics
12/01/2005WO2005113019A2 Methods for the treatment of autoimmune diseases
12/01/2005WO2005112992A1 P. gingivalis vaccine
12/01/2005WO2005112985A2 Means and method for diagnosis prophylaxis and therapy of connective tissue diseases
12/01/2005WO2005112983A2 Modulation of immunoglobulin production and atopic disorders
12/01/2005WO2005112978A2 Methods and compositions related to delivery of chemical compounds to invertebrate embryos
12/01/2005WO2005112975A1 Use of histones for the early diagnosis and/or preventative therapy of virally-infected living cells and a biochip for carrying out said diagnosis
12/01/2005WO2005112903A2 Use of ghrelin antagonists for improving cognition and memory
12/01/2005WO2005112742A2 Diagnostic test strip for collecting and detecting an analyte in a fluid sample and method for using same
12/01/2005WO2005112628A2 Sptrx-3 polypeptide and nucleic acid. uses thereof in methods and compositions for evaluation of male fertility
12/01/2005WO2005112554A2 Handheld medical logging apparatus and method
12/01/2005WO2005106477A3 Biomolecule immobilisation using atmospheric plasma technology
12/01/2005WO2005094391A3 METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING DISEASE ASSOCIATED WITH αVβ5 INTEGRIN
12/01/2005WO2005087954A3 Roles of foxc2, pdgfr, vegfr3 in lymphatic vessel development
12/01/2005WO2005084404A3 Microfluidic biosensor and methods of use
12/01/2005WO2005073408A3 Small segments of dna determine animal identity and source
12/01/2005WO2005071401A3 Homogeneous multiplex assay for nucleic acid targets
12/01/2005WO2005069975A3 Lysyl oxidase-like 1 (loxl1) and elastogenesis
12/01/2005WO2005066605A3 Method and device for determining the content of lubricating oil in an exhaust gas mixture
12/01/2005WO2005065015A3 Neutralizing antibodies and methods of use thereof
12/01/2005WO2005062916A3 Methods for generating multimeric molecules
12/01/2005WO2005057212A3 Device for sensing contaminants
12/01/2005WO2005057169A3 Homogeneous competition assays
12/01/2005WO2005054932A3 Simple matrix addressing in a display
12/01/2005WO2005054509A3 Assay and treatment
12/01/2005WO2005052542A3 Method and composition useful for determining fk 506
12/01/2005WO2005051977A3 Conditional allele system
12/01/2005WO2005050200A3 Screening assays and methods of tumor treatment
12/01/2005WO2005037195A3 Compounds and methods for treating and preventing exercise-induced cardiac arrhythmias
12/01/2005WO2005032595A3 Methods and compositions for the inhibition of stat5 in prostate cancer cells
12/01/2005WO2005032491A3 Methods and compositions for mycoplasma pneumoniae exotoxins
12/01/2005WO2005027831A3 Modulators of p-selectin glycoprotein ligand 1
12/01/2005WO2005026191A3 Size-controlled macromolecule
12/01/2005WO2005024043A3 Methods for identifying, diagnosing, and predicting survival of lymphomas
12/01/2005WO2005016126A3 Multifactorial assay for cancer detection
12/01/2005WO2005006949A3 Methods for predicting development of auto-immune diseases and treatment of same
12/01/2005WO2005003305A3 Usps as modifiers of the beta catenin pathway and methods of use
12/01/2005WO2004111262A8 Method of identifying a selective chemotherapeutic agent
12/01/2005WO2004099219A3 Silanyl n-alkanal compounds, method for production and use thereof
12/01/2005WO2004092727A3 Compound libraries and methods for drug discovery
12/01/2005WO2004049385A3 Constellation mapping and uses thereof
12/01/2005WO2004020979A3 Methods of assaying for cell cycle modulators using components of the ubiquitin ligation cascade
12/01/2005WO2004011627A3 A recombinant host cell line screening system for drugs with potential anti-cancer and anti-(retro-) viral activity
12/01/2005WO2003064588A3 Structural basis of quorum sensing signal generation and methods and therapeutic agents derived therefrom
12/01/2005WO2003027632A3 Use of isogenic human cancer cells for high-throughput screening and drug discovery
12/01/2005US20050268350 Identification and purification of higher order transcription complexes from transgenic non-human animals
12/01/2005US20050267693 Method, system, and apparatus for compactly storing a subject genome
12/01/2005US20050267692 Method and system for the detection of atypical sequences via generalized compositional methods
12/01/2005US20050267691 Information service system based on genetic character
12/01/2005US20050267689 Method to automatically identify peak and monoisotopic peaks in mass spectral data for biomolecular applications
12/01/2005US20050267688 Method for enhanced accuracy in predicting peptides elution time using liquid separations or chromatography
12/01/2005US20050267687 System for predicting three-dimensional structure of protein
12/01/2005US20050267357 fMRI system for detecting symptoms associated with Attention Deficit Hyperactivity Disorder
12/01/2005US20050267294 Antibodies with increased affinities for anthrax antigens
12/01/2005US20050267059 Syk-targeted nucleic acid interference
12/01/2005US20050267036 Peptide sequence derived from the C-terminus of CaV2.2. and inhibits the interaction of CaV2.2 with Mint1-PDZ1, a glutathione S transferase fusion protein; neurotransmitter-release angonists of CaV2.2, the pore-forming subunit of N-type of voltage-dependent calcium channels; antinocciceptive agents
12/01/2005US20050267029 Compounds which modulate amyloidogenesis and methods for their identification and use
1 ... 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 ... 3937